(MOTS) |
| 0 (0%) 10-12 13:52 |
| Open: | |
| High: | |
| Low: | |
| Volume: | 0 |
| Market Cap: | 0(M) |
| PE Ratio: | 0 |
| Exchange: | |
| Industry: | |
| Sector: |
| Technical analysis | ||||
 |
||||
| sell | buy | |||
| Resistance 2: | 26.73 |
| Resistance 1: | 23.56 |
| Pivot price: | 21.61 |
| Support 1: | 18.42 |
| Support 2: | 15.32 |
| 52w High: | |
| 52w Low: |
Financials
| EPS | -2.010 |
| Book Value | 36.060 |
| PEG Ratio | 2.02 |
| Gross Profit | 4.341 |
| Profit Margin (%) | -5.21 |
| Operating Margin (%) | -0.12 |
| Return on Assets (ttm) | 1.2 |
| Return on Equity (ttm) | -5.1 |
Company news
Sat, 10 Oct 2026
MOTS-c: The Tiny Mitochondrial Peptide That Behaves Differently in Health and Cancer - Bioengineer.org
Sat, 10 Oct 2026
Mitochondrial-derived peptide MOTS-c rescues vascular endothelial damage via PLA2G6 in diabetic retinopathy - Nature
Fri, 09 Oct 2026
Kwik Fit Launches 'Kwik Chat' to Promote Mental Wellbeing During MOTs - Adland
Mon, 28 Sep 2026
Seedy K’s Pigskin Palaver: Mediocrity, Bon Mots & Bad Woofs +++ - Card Chronicle
Mon, 21 Sep 2026
Frank Mots Kite Festival 2026 - UWM Post
Thu, 17 Sep 2026
Umbrella Lab Announces Documentation And Traceability Update For MOTS-C Peptide - markets.businessinsider.com
 StockChart iOS |
 StoxlineLite iOS |
StoxlineLite iOS |
 OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |
